| |
|
|
|
Agile Therap  
|
|
3 0.06 (0.02%) |
01-25 16:00 |
|
Open: |
2.93 |
Pre close: |
2.94 |
Target:
|
3.56
|
|
High: |
3.005 |
Low: |
2.845 |
Resistance:
|
3.05
3.56
|
|
Volume: |
2,328,143 |
Market Cap: |
263M |
Support:
|
2.86
2.74
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.95
 |
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
2.88 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
2.99  |
Stochastic Oscillator |
%K(14,3):
|
74.19 |
|
MA(250): |
2.81 |
%D(3): |
74.63 |
|
Average Volume(K) |
3-Month: |
96483
|
52-Week |
High:
|
4.76 |
|
10-Days: |
107898 |
Low: |
1.35 |
|
RSI |
RSI(14):
|
59.51 |
Change(%): |
-23.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.513 |
Return on Equity (ttm) |
-82.1 |
Shares Out. (M) |
87.43 |
|
EPS Est. Current Year |
-1.020 |
Return on Assets (ttm) |
-39.0 |
Shares Float (M) |
70.64 |
|
EPS Est. Next Year |
-0.980 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.98 |
|
EPS Est. Next Quarter |
-0.260 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
49.81 |
|
Forward EPS |
-0.580 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
3390 |
|
Book Value (p.s.) |
0.760 |
EBITDA (p.s.) |
-0.437 |
P/E |
-5.85 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.95 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-33.24 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-17.69 |
P/CF |
-7.89 |
|
|
|
|
|
|
